Anonymous
Guest
Anonymous
Guest
I liked his latest interview in the New York Times, but it either illuminated his incompetence at Novartis or was disingenuous at best. If he really wanted to 'fix the problems' in his biggest market (the US), he'd start with;
The insane forecasts that get pushed down by Basel.
The incompetent Senior Leadership that doesn't push back against them because we don't have the right data to take to our customers.
The voodoo that goes into the goaling and incentive plan for the field force.
The product shortages at the pharmacy level.
When is anyone other than the field force accountable for any of this? If Senior Leadership really wants to know why the field is so disconnected from HQ, it's because they stopped listening to us for the last three years. Good luck with your listening tour, maybe someday people will actually take our suggestions seriously. Until then, we'll keep giving you as many green fire trucks as you ask for.
The insane forecasts that get pushed down by Basel.
The incompetent Senior Leadership that doesn't push back against them because we don't have the right data to take to our customers.
The voodoo that goes into the goaling and incentive plan for the field force.
The product shortages at the pharmacy level.
When is anyone other than the field force accountable for any of this? If Senior Leadership really wants to know why the field is so disconnected from HQ, it's because they stopped listening to us for the last three years. Good luck with your listening tour, maybe someday people will actually take our suggestions seriously. Until then, we'll keep giving you as many green fire trucks as you ask for.